| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/30/2013 | CA2383154C Baff receptor (bcma), an immunoregulatory agent |
| 04/25/2013 | WO2013059593A1 Anti-cd22 chimeric antigen receptors |
| 04/25/2013 | WO2013056308A1 Novel forms of plant defensins |
| 04/25/2013 | WO2013019604A3 Protein production method |
| 04/25/2013 | WO2012177444A3 Glucagon/glp-1 receptor co-agonists |
| 04/25/2013 | WO2012021512A8 Erythrocyte-binding therapeutics |
| 04/25/2013 | US20130102759 Synthetic Oligosaccharides for Moraxella Vaccine |
| 04/25/2013 | US20130102072 Suppression of b-cell apoptosis in transgenic animals expressing humanized immunoglobulin |
| 04/25/2013 | US20130101555 Proproteins and Methods of Use Thereof |
| 04/25/2013 | CA2852874A1 Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
| 04/25/2013 | CA2851795A1 Anti-cd22 chimeric antigen receptors |
| 04/25/2013 | CA2851635A1 Etanercept formulations stabilized with amino acids |
| 04/24/2013 | CN103068854A Fusion protein having factor VII activity |
| 04/24/2013 | CN103068850A Single -chain variable fragment anti-cd133 antibodies and uses thereof |
| 04/24/2013 | CN103068838A Vaccine against streptococcal infections based on recombinant proteins |
| 04/24/2013 | CN103060354A Combined excitable fluorescent protein and application thereof |
| 04/24/2013 | CN103060342A Bt toxin CrylAn-loop2-P2S with high toxicity to rice nilaparvata lugens and engineering bacteria |
| 04/24/2013 | CN103059143A Method for preparing enramycin antigen |
| 04/24/2013 | CN103059142A Recombinant protein of antigen to porcine circovirus and antigen to porcine reproductive and respiratory syndrome virus, and preparation method and application of recombinant protein |
| 04/24/2013 | CN103059141A Application of ubiquitin-binding domain fusion protein in detection and separation of ubiquitination protein |
| 04/24/2013 | CN103059140A Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in treatment of allergies |
| 04/24/2013 | CN103059139A Methicillin-resistant Staphylococcus aureus (MRSA) vaccine recombinant proteantigen I12C, and preparation method and application thereof |
| 04/24/2013 | CN103059104A Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| 04/24/2013 | CN101684159B Protein derivatives of human granzyme B, and use thereof in targeted therapy on adenocarcinoma |
| 04/24/2013 | CN101555284B Truncated-type human ciliary nerve nutrition factor active segment and fusion protein thereof |
| 04/23/2013 | US8426167 Methods for producing fusion polypeptides or enhancing expression of fusion polypeptides |
| 04/23/2013 | US8426144 Monocyte-derived nucleic acids and related compositions and methods |
| 04/23/2013 | CA2493081C Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 04/23/2013 | CA2400838C Novel method for down-regulation of amyloid |
| 04/23/2013 | CA2381125C Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 04/23/2013 | CA2308571C Single-chain bifunctional glycoprotein hormones |
| 04/18/2013 | WO2013053080A1 Anti-tumour fusion protein and coding gene and use thereof |
| 04/18/2013 | WO2013053008A2 Molecules which bind clec9a |
| 04/18/2013 | US20130096072 Zymogen Activators |
| 04/18/2013 | US20130096065 Neublastin variants |
| 04/18/2013 | US20130095513 Resonance Energy Transfer Assay with Cleavage Sequence and Spacer |
| 04/18/2013 | US20130095132 Tuberculosis vaccines comprising antigens expressed during the latent infection phase |
| 04/18/2013 | US20130095102 Dimeric fusion proteins and related compositions and methods |
| 04/17/2013 | EP2581389A1 Fusion protein of exendin-4 and its analog, preparation method and use thereof |
| 04/17/2013 | EP2580331A1 Nuclease activity of tal effector and foki fusion protein |
| 04/17/2013 | CN103045633A Recombination human vascular endothelial growth factor-165 protein and preparation method thereof |
| 04/17/2013 | CN103045627A Method for preparing fused protein in cell |
| 04/17/2013 | CN103044556A Recombined fusion protein VIP-TAT and application thereof |
| 04/17/2013 | CN103044555A Fused protein containing cFms extracellular fragments, preparation method and applications of fused protein with cFms extracellular fragments |
| 04/17/2013 | CN103044554A Human urinary trypsin inhibitor (hUTI) of reorganization-dimerization and preparation method and application thereof |
| 04/17/2013 | CN103044549A Preparation method of apis cerana antimicrobial peptide AccRoyalisin polyclonal antibody and use thereof |
| 04/17/2013 | CN102304536B Eukaryotic fused expression product of two marine animal antibacterial peptide genes, and preparation method thereof |
| 04/17/2013 | CN101914561B Fusion protein with antibacterial and repairing function and production method and application thereof |
| 04/17/2013 | CN101875688B Folic acid modification step of method for preparing recombinant tumor specific apoptosis factor and application of products of recombinant tumor specific apoptosis factor |
| 04/17/2013 | CN101433715B Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/16/2013 | US8420779 Compositions and methods for producing bioactive fusion proteins |
| 04/16/2013 | US8420102 Compositions that include hemagglutinin |
| 04/16/2013 | US8420094 Fusion proteins comprising a fragment of Vibrio cholerae exotoxin A |
| 04/16/2013 | CA2628315C Compositions and methods for the detection of trypanosoma cruzi infection |
| 04/16/2013 | CA2476846C Method for detection of leptin receptor ligands |
| 04/16/2013 | CA2465973C Posh nucleic acids, polypeptides and related methods |
| 04/16/2013 | CA2412504C Antigenic polypeptides |
| 04/16/2013 | CA2361246C Identification of specific differentially expressed antigens |
| 04/11/2013 | WO2013051718A1 Chimeric antigen receptor |
| 04/11/2013 | WO2012178136A3 Fusion proteins of bacterial luciferase as multicolor luminescent sensors |
| 04/11/2013 | US20130090454 Light-Sensitive Ion-Passing Molecules |
| 04/11/2013 | US20130089553 Method for making heteromultimeric polypeptides |
| 04/11/2013 | US20130089550 Novel ctla4-ig immunoadhesins |
| 04/11/2013 | US20130089549 B cell activating factor antagonist and preparation method and use thereof |
| 04/11/2013 | US20130089548 Method and compositions to induce apoptosis of tumoral cells expressing shh |
| 04/11/2013 | US20130089516 Protease activated cytokines |
| 04/11/2013 | CA2850944A1 Human notch1 decoys |
| 04/10/2013 | EP2578603A1 B cell activating factor antagonist and preparation method and use thereof |
| 04/10/2013 | EP2576790A1 Vitronectin:keratinocyte growth factor chimeras |
| 04/10/2013 | EP2576626A2 Stable, functional chimeric cellobiohydrolase class i enzymes |
| 04/10/2013 | EP2576625A2 Fusion protein having factor vii activity |
| 04/10/2013 | EP2576624A1 Recombinant human g-csf dimer and use thereof for the treatment of neurological diseases |
| 04/10/2013 | EP2576620A1 Single -chain variable fragment anti-cd133 antibodies and uses thereof |
| 04/10/2013 | CN103038351A Vitronectin:keratinocyte growth factor chimeras |
| 04/10/2013 | CN103038252A Improved complement receptor 2 (CR2) targeting groups |
| 04/10/2013 | CN103031268A OGP-rhLeptin fusion protein transgenic engineering strain |
| 04/10/2013 | CN102153634B Bt binary toxin protein, gene for coding Bt binary toxin protein and application |
| 04/10/2013 | CN102070717B Fusion protein, preparation method thereof, DNA sequence for coding protein, expression vector, host cell and protein-containing medicinal compoisition |
| 04/10/2013 | CN101403746B Conjugate used for immunity detection |
| 04/09/2013 | US8415129 Nucleic acid modifying enzymes |
| 04/09/2013 | CA2546406C Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 04/09/2013 | CA2455237C Compositions and methods for generating chimeric heteromultimers |
| 04/09/2013 | CA2383470C Inhibition of secretion from non-neuronal cells |
| 04/09/2013 | CA2325341C Mutagenized il13-based chimeric molecules |
| 04/09/2013 | CA2241373C Compositions and methods for t-cell activation comprising gm-csf and tumor antigen fusion proteins |
| 04/04/2013 | WO2013049254A1 Hybrid constant regions |
| 04/04/2013 | WO2013044792A1 Nicotinamide adenine dinucleotide gene encoding fluorescent probe, preparation method therefor and application thereof |
| 04/04/2013 | WO2013021206A3 Stable proteins |
| 04/04/2013 | WO2013010225A8 Enzymes for degrading organophosphates |
| 04/04/2013 | US20130085099 Therapeutic agents comprising elastin-like peptides |
| 04/04/2013 | US20130084295 Anti-interferon-alpha antibodies |
| 04/04/2013 | US20130084290 Antibodies to Thymic Stromal Lymphopoietin (TSLP) Receptor Molecules and Uses Thereof |
| 04/04/2013 | CA2849765A1 Hybrid constant regions |
| 04/04/2013 | CA2849471A1 Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus |
| 04/03/2013 | EP2574632A1 A mycobacterium tuberculosis fusion protein and uses thereof |
| 04/03/2013 | EP2574631A1 Filler for affinity chromatography and method for isolating immunoglobulin |
| 04/03/2013 | CN1555268B Therapeutic agents comprising pro-apoptotic proteins |
| 04/03/2013 | CN1526018B Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 04/03/2013 | CN103014012A Fusarium specific single-chain antibody and preparation method and application thereof |
| 04/03/2013 | CN103014011A Humanized single-chain antibody gene capable of resisting hepatitis C virus non-structural 3/4A (HCV NS3/4) protein |